Search research articles
Contact Us
Filters
Showing results (211-220 of 361) with videos related to
Page
of 37
Sort By:
The Lancet. Infectious Diseases
|
March 19, 2011
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M Marty, Per Ljungman, Genovefa A Papanicolaou, et al.
Annals of Hematology
|
April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
Mikkael A Sekeres, Michael Schuster, Magalie Joris, et al.
Bone Marrow Transplantation
|
May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
Arnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
Journal of Clinical Microbiology
|
January 21, 2025
Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological disease
Hanne Lamberink, Sammy Huygens, Robina Aerts, et al.
Blood Cancer Journal
|
March 28, 2024
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2023
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, et al.
Haematologica
|
July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Catherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Blood
|
July 10, 2014
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Hartmut Döhner, Michael Lübbert, Walter Fiedler, et al.
Experimental Hematology
|
October 11, 2003
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies
Jan J Cornelissen, Bronno van der Holt, Eefke J Petersen, et al.
Page
of 37
Search research articles
Search
Showing results (211-220 of 361) with videos related to
Sort By:
Page
of 37
The Lancet. Infectious Diseases
|
March 19, 2011
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M Marty, Per Ljungman, Genovefa A Papanicolaou, et al.
Annals of Hematology
|
April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
Mikkael A Sekeres, Michael Schuster, Magalie Joris, et al.
Bone Marrow Transplantation
|
May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
Arnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
Journal of Clinical Microbiology
|
January 21, 2025
Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological disease
Hanne Lamberink, Sammy Huygens, Robina Aerts, et al.
Blood Cancer Journal
|
March 28, 2024
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
Niek G van der Maas, Jurjen Versluis, Kazem Nasserinejad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2023
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, et al.
Haematologica
|
July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Catherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Blood
|
July 10, 2014
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Hartmut Döhner, Michael Lübbert, Walter Fiedler, et al.
Experimental Hematology
|
October 11, 2003
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies
Jan J Cornelissen, Bronno van der Holt, Eefke J Petersen, et al.
Page
of 37